financetom
Business
financetom
/
Business
/
Japan's Sumitomo Corp net profit down 32%, misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Sumitomo Corp net profit down 32%, misses estimates
May 1, 2024 10:56 PM

TOKYO (Reuters) - Japanese trading house Sumitomo Corp ( SSUMF ) reported net profit for the fiscal year ended in March fell 31.7% from a year earlier to 386.4 billion yen ($2.5 billion), missing estimates.

A LSEG poll of analysts had forecast Sumitomo's ( SSUMF ) net profit for the fiscal year at 504.9 billion yen. Sumitomo ( SSUMF ) said its net profit for the year ending in March 2025 is forecast at 530 billion yen.

($1 = 155.8700 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Twelve Seas Investment Company III Completes $172,500,000 Initial Public Offering
Twelve Seas Investment Company III Completes $172,500,000 Initial Public Offering
Mar 10, 2026
Los Angeles, California, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III ( TWLVU ) (the “Company”) today announced the closing of its initial public offering of 17,250,000 units, including 2,250,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $172,500,000. Of...
Tiziana Life Sciences CEO Increases Stake With Share Purchase
Tiziana Life Sciences CEO Increases Stake With Share Purchase
Mar 10, 2026
03:33 PM EST, 12/15/2025 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Monday its CEO, Ivor Elrifi, purchased 163,400 shares of common stock, bringing his total stake to 357,848 shares. Shares of the company were down over 17% in recent trading. Price: 1.47, Change: -0.31, Percent Change: -17.19 ...
AstraZeneca Says Enhertu Approved in US as First-Line HER2 Positive Metastatic Breast Cancer Treatment
AstraZeneca Says Enhertu Approved in US as First-Line HER2 Positive Metastatic Breast Cancer Treatment
Mar 10, 2026
03:31 PM EST, 12/15/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday that Enhertu, in combination with pertuzumab, has been approved in the US as a first-line treatment for adult patients with unresectable or metastatic HER2 positive breast cancer. The approval has been based on Destiny-Breast09 phase 3 study results that showed Enhertu in combination with pertuzumab reduced the...
Uber Stock Drops After Regulators Target Billing And Cancellation Tactics
Uber Stock Drops After Regulators Target Billing And Cancellation Tactics
Mar 10, 2026
Uber Technologies Inc ( UBER ) shares dropped on Monday as regulators ramped up scrutiny of the company's subscription practices. Uber Technologies ( UBER ) shares are retreating from recent levels. What’s weighing on UBER ( UBER ) shares? What Happened: The Federal Trade Commission (FTC), joined by 21 states and Washington, D.C., filed an amended complaint accusing Uber (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved